Rxsight Inc (RXST)vsStryker Corporation (SYK)
RXST
Rxsight Inc
$6.26
-2.03%
HEALTHCARE · Cap: $263.69M
SYK
Stryker Corporation
$327.65
-0.26%
HEALTHCARE · Cap: $125.72B
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 18577% more annual revenue ($25.12B vs $134.48M). SYK leads profitability with a 12.9% profit margin vs -29.0%. SYK earns a higher WallStSmart Score of 65/100 (C+).
RXST
Avoid34
out of 100
Grade: F
SYK
Buy65
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for RXST.
Margin of Safety
+16.8%
Fair Value
$393.59
Current Price
$327.65
$65.94 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 55.9% YoY
Large-cap with strong market position
Strong operational efficiency at 27.2%
Generating 1.9B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -14.0% — below average capital efficiency
Revenue declined 18.9%
Expensive relative to growth rate
Premium valuation, high expectations priced in
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : RXST
The strongest argument for RXST centers on Price/Book.
Bull Case : SYK
The strongest argument for SYK centers on EPS Growth, Market Cap, Operating Margin. Revenue growth of 11.4% demonstrates continued momentum.
Bear Case : RXST
The primary concerns for RXST are EPS Growth, Market Cap, Return on Equity.
Bear Case : SYK
The primary concerns for SYK are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
RXST profiles as a turnaround stock while SYK is a value play — different risk/reward profiles.
RXST carries more volatility with a beta of 1.15 — expect wider price swings.
SYK is growing revenue faster at 11.4% — sustainability is the question.
SYK generates stronger free cash flow (1.9B), providing more financial flexibility.
Bottom Line
SYK scores higher overall (65/100 vs 34/100) and 11.4% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Rxsight Inc
HEALTHCARE · MEDICAL DEVICES · USA
Rxsight Inc. is a pioneering healthcare technology company specializing in advanced vision correction solutions through its innovative diagnostic and surgical techniques in refractive eye surgery. Utilizing proprietary software and precision-guided laser technology, the company significantly improves patient outcomes and overall quality of life. Rxsight's strong intellectual property portfolio and strategic partnerships further enhance its competitive positioning within the expanding ophthalmic market. With a robust commitment to innovation and excellence, Rxsight is strategically poised for significant growth and impact in the evolving landscape of eye care.
Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?